Outcome of patients with recurrent hepatocellular carcinoma after liver transplantation

Although current selection criteria have led to a significant decrease in HCC recurrence rates after liver transplantation (LT), recent studies have reported recurrent rates around 10%. Only few studies have addressed therapeutic options and outcome of patients with recurrent HCC. The aim of our study was to evaluate the survival of patients with HCC recurrence and to identify specific risk factors. We analyzed the data of 202 HCC patients (26 f/176m). Their median age was 60 (31–75) years. The main underlying liver diseases were viral cirrhosis in 51% and (non) alcoholic fatty liver disease in 33%; 40% had CPC…